Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways

Bibliographic Details
Main Authors:	Giannis Mountzios, Giuseppe Luigi Banna, Christian Rolfo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Oncology
Subjects:	thoracic malignancies lung cancer chemotherapy immunotherapy resistance molecular pathways
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.997404/full

Similar Items

Progress of Chimeric Antigen Receptor Gene Modified-T Cell Immunotherapy for Thoracic Malignancies
by: CHEN Fukun, et al.
Published: (2023-10-01)

Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
by: Long Chen, et al.
Published: (2022-07-01)

Pump operations in locally advanced thoracic malignancies
by: Saulius Cicėnas, et al.
Published: (2013-01-01)

Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies
by: Hiroyuki Kozai, et al.
Published: (2024-02-01)

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies
by: Shenhe Jin, et al.
Published: (2022-12-01)

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy
by: Dantong Sun, et al.
Published: (2024-01-01)

The Safety of Chemotherapy for Ovarian Malignancy during Pregnancy
by: Naidong Xing, et al.
Published: (2022-12-01)

Immunotherapy vs. Chemotherapy in Subsequent Treatment of Malignant Pleural Mesothelioma: Which Is Better?
by: Xiaotong Guo, et al.
Published: (2023-03-01)

Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series
by: Yongbo Xiang, et al.
Published: (2023-07-01)

Malignant solitary fibrous tumor of thoracic spine with distant metastases: Second reported case and review of the literature
by: Rituparna Biswas, et al.
Published: (2017-01-01)

Editorial: Immunotherapy for hematological malignancies in children
by: Yusi Zhou, et al.
Published: (2023-10-01)

Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors
by: Zhengfeng Zhang, et al.
Published: (2023-07-01)

Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis
by: Yueyuan Yao, et al.
Published: (2024-02-01)

The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
by: Shehab Mohamed, et al.
Published: (2023-04-01)

Tackling Immunotherapy Resistance: Developing Rational Combinations of Immunotherapy and Targeted Drugs
by: Elena Cojocaru, et al.
Published: (2019-05-01)

Adjuvant chemotherapy combined with immunotherapy in patients with cholangiocarcinoma after radical resection
by: Xiao‐hui Li, et al.
Published: (2023-12-01)

Evaluating the Survival Rate and the Secondary Malignancies after Treating Hodgkin's Lymphoma Patients with Chemotherapy Regimens
by: Ahmad Ahmadzadeh, et al.
Published: (2014-06-01)

Editorial: DNA methylation, tumor microenvironment and their effects in immunotherapy and drug resistance in thoracic tumors
by: Limeng Qu, et al.
Published: (2024-01-01)

Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial
by: Lili Liu, et al.
Published: (2023-12-01)

Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single‐center retrospective study
by: Kei Kunimasa, et al.
Published: (2022-11-01)

Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
by: Sara Small, et al.
Published: (2021-11-01)

Diffuse malignant peritoneal mesothelioma: A review
by: Luanbiao Sun, et al.
Published: (2023-01-01)

Safety and short-term outcomes of gastrectomy after preoperative chemotherapy plus immunotherapy versus preoperative chemotherapy: a retrospective cohort study
by: Yinkui Wang, et al.
Published: (2022-12-01)

Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy
by: Susana Cedres, et al.
Published: (2023-12-01)

Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prospective Report
by: Stefano Bongiolatti, et al.
Published: (2021-11-01)

Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccines
by: Marc Mansour, et al.
Published: (2011-08-01)

Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study
by: Qi Wei, et al.
Published: (2024-03-01)

Editorial: Reviews in thoracic oncology
by: Nikolaos I. Kanellakis, et al.
Published: (2023-05-01)

Adjuvant chemotherapy-associated febrile neutropenia in a patient with breast malignancy: A case report
by: Esravila Ariya Wibisono, et al.
Published: (2020-08-01)

Thoracic ultrasound use in hospitalized and ambulatory adult patients: a quantitative picture
by: N. Xirouchaki, et al.
Published: (2024-02-01)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
by: Patrycja Śliwa-Tytko, et al.
Published: (2022-05-01)

Comparison of video-assisted pleurectomy/decortication surgery plus hyperthermic intrathoracic chemotherapy with VATS talc pleurodesis for the treatment of malignant pleural mesothelioma: A pilot study
by: Marcello Migliore, et al.
Published: (2023-06-01)

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma
by: Diego Cortinovis, et al.
Published: (2021-03-01)

The pharmacoeconomic efficacy of chemotherapy for malignant neoplasms of the bronchus and lung
by: S. K. Yarovoy, et al.
Published: (2020-04-01)

A case report of hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) for malignant peritoneal mesothelioma
by: Hanjian Liu, et al.
Published: (2023-12-01)

High-Frequency Electroporation and Chemotherapy for the Treatment of Cutaneous Malignancies: Evaluation of Early Clinical Response
by: Phoebe Lyons, et al.
Published: (2023-06-01)

Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes
by: Urska Janzic, et al.
Published: (2024-02-01)

Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
by: Zhao Qiang, et al.
Published: (2023-02-01)

Emerging Therapeutic Targets and Drug Resistance Mechanisms in Immunotherapy of Hematological Malignancies
by: Wioletta Olejarz, et al.
Published: (2023-12-01)

Chinese expert consensus on immunotherapy for gynecological malignant tumors (2023 edition)
by: Society of Onco-Endocrinology of Chinese Anti-Cancer Association
Published: (2023-10-01)